In its interview with Zhou Chao published on 2026-11-10, ChinaVenture recorded his impression that investors now care more about who could replace the company. This describes the interviewee’s own fundraising discussions and cannot be generalized into a standard approach used by all investors. For domestic science and technology companies, it suggests another question for assessing investor fit: when an institution discusses alternatives, does it also recognize the customer’s option to keep using an existing method?

In its financing announcement dated 2026-11-10, Blue J quoted JMI Equity on unique value for specific markets. This overseas information is background only on assessing specialized markets. It neither establishes that the firms use the method discussed here nor recommends their products. Youdu Capital serves domestic financing for Chinese technology companies and does not provide cross-border financial services. The following investor-discussion scenarios do not describe either firm’s actual investment decisions.

A common presentation format places technically similar companies in a competitor table and compares speed, precision and features. This can explain differences among peers without explaining why a customer would buy. Suppose a factory can still complete its work through manual sampling, outside services or old equipment. It may choose none of the technical leaders and maintain the status quo. This is an analytical hypothetical, not a factual description of any named customer.

The first causal mechanism concerns different decisions. R&D teams compare technical approaches, while customer managers decide whether to change a process that still functions. Customers may accept some loss of efficiency to avoid additional management work, or allocate a limited budget to a more urgent process. Consequently, a performance threshold that no peer can meet does not automatically generate demand. An empty space in a competitor table cannot simply be counted as an obtainable market.

The second effect concerns an institution’s revenue assessment. An investment team familiar only with technology companies may carefully verify peer differences while lacking evidence about when customers would abandon existing methods. Sales forecasts can then depend on a widening technical advantage even though customers’ budget priorities remain unchanged. The issue is whether the team’s expertise covers the actual choices underlying this round’s revenue assumptions. Both sides need to identify the gap clearly.

When approaching investors, the company can show anonymized records of purchasing opportunities: how customers previously worked, what prompted comparison, who could authorize spending, and why they ultimately bought or deferred. Opportunities that did not result in purchases should remain in the record. Ask the institution to explain which existing method is most likely to compete with the product and what further evidence it needs. The focus is whether its additional questions test the revenue premise; immediate agreement is not proof of fit.

This also helps organize the participating teams. Institutions strong in technical approaches can continue examining performance, while teams familiar with customer operations can discuss budgets and alternatives. Founders need not require every institution to cover everything independently. Before advancing the round, however, they should confirm that someone is actually undertaking the key commercial assessment. The presence of an industry expert at a meeting does not establish that this has happened. Examine the questions asked, evidence requested and scope of conclusions that can be reached.

For early projects that still lack customer records, an institution’s willingness to discuss existing methods does not establish demand either. Narrow the open questions into a defined comparison: which work the customer would change, what result it needs to see and who can confirm it. Institutions can help test assumptions, but actual purchasing remains the customer’s decision. Founders should not change their definition of competition to suit an investor or describe an unavailable budget as released. Preserving unanswered questions allows technical and commercial assessments to accumulate their own evidence and makes it easier to explain what information has been added at the next discussion.

It is also necessary to distinguish customer reluctance to change from the company’s temporary inability to deliver. The former calls for testing purchasing motivations; the latter calls for product and delivery capabilities. If both are described simply as a long sales cycle, an investor may suggest more channels while the company invests in a purchasing window that does not yet exist. Review real opportunities to locate where progress stopped, then discuss which condition the next R&D or sales expenditure is intended to change. Do not invent customer willingness to complete a plan.

Over the next three to six months, the first three months can focus on one defined application, updating records monthly for purchases, delays and decisions to retain existing methods. If technical comparisons proceed smoothly but most opportunities stop at budget discussions, prioritize evidence about what would trigger a change and seek discussion teams able to explain those conditions. If purchasing motivation is clear but performance is the constraint, continue technical verification. The emphasis on commercial assessment here should not weaken engineering evidence.

During the following three months, if new records show continued purchasing by a customer category under comparable conditions, update revenue assumptions with the relevant institutions. If customers still choose existing methods, retain that result and revise the expansion premise. Investor fit ultimately requires someone able to test whether customers need to change, beyond providing a more complete list of peers. This article does not rank any institution’s abilities, promise financing or sales outcomes, or provide specific investment, legal or tax advice. Consult qualified professional institutions on confidentiality and customer agreements.

Sources 首发丨联合拿下国内聚变磁体最大单,“卖铲人”周超融资超10亿 (2026-11-10) https://www.chinaventure.com.cn/news/114-20261110-393981.html Blue J Announces US$176 Million Series E to Put AI Agents to Work for Tax Professionals (2026-11-10) https://www.bluej.com/ca/blog/blue-j-announces-series-e-funding

Content note: This article was drafted with AI assistance and reviewed through an independent AI process, using the listed public sources. It contains no original interviews, and no first-hand testing of the products, services or methods discussed was conducted. Checking public sources is not a field investigation or first-hand experience.